JPWO2022250013A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022250013A5 JPWO2022250013A5 JP2023523465A JP2023523465A JPWO2022250013A5 JP WO2022250013 A5 JPWO2022250013 A5 JP WO2022250013A5 JP 2023523465 A JP2023523465 A JP 2023523465A JP 2023523465 A JP2023523465 A JP 2023523465A JP WO2022250013 A5 JPWO2022250013 A5 JP WO2022250013A5
- Authority
- JP
- Japan
- Prior art keywords
- antitumor agent
- agent according
- liposome
- cancer
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192366P | 2021-05-24 | 2021-05-24 | |
| PCT/JP2022/021103 WO2022250013A1 (ja) | 2021-05-24 | 2022-05-23 | 抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022250013A1 JPWO2022250013A1 (https=) | 2022-12-01 |
| JPWO2022250013A5 true JPWO2022250013A5 (https=) | 2024-02-26 |
Family
ID=84228802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523465A Pending JPWO2022250013A1 (https=) | 2021-05-24 | 2022-05-23 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240099975A1 (https=) |
| EP (1) | EP4349337A4 (https=) |
| JP (1) | JPWO2022250013A1 (https=) |
| CN (1) | CN117440810A (https=) |
| TW (1) | TW202313031A (https=) |
| WO (1) | WO2022250013A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202434243A (zh) * | 2022-11-21 | 2024-09-01 | 日商富士軟片股份有限公司 | 含有內含拓普替康或其鹽之脂質體組成物及ｄｎａ損傷修復抑制劑之組合醫藥 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100679906B1 (ko) | 1998-09-16 | 2007-02-07 | 알자 코포레이션 | 리포솜-엔트랩된 토포이소머라제 억제제 |
| JP2004501955A (ja) | 2000-06-30 | 2004-01-22 | アイネックス ファーマシューティカルズ コーポレイション | リポソーム抗新生物薬剤およびその使用 |
| EP1750673B1 (en) | 2004-05-17 | 2009-12-02 | Tekmira Pharmaceuticals Corporation | Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof |
| US20090285878A1 (en) | 2004-11-05 | 2009-11-19 | Tekmira Pharmaceuticals Corporation | Compositions and methods for stabilizing liposomal drug formulations |
| RU2734900C1 (ru) | 2017-03-31 | 2020-10-26 | Фуджифилм Корпорэйшн | Липосомальная композиция и фармацевтическая композиция |
| TWI837189B (zh) * | 2018-10-01 | 2024-04-01 | 日商富士軟片股份有限公司 | 包含內含藥物之脂質體組成物及鉑製劑之組合醫藥 |
-
2022
- 2022-05-23 JP JP2023523465A patent/JPWO2022250013A1/ja active Pending
- 2022-05-23 TW TW111119106A patent/TW202313031A/zh unknown
- 2022-05-23 WO PCT/JP2022/021103 patent/WO2022250013A1/ja not_active Ceased
- 2022-05-23 EP EP22811283.5A patent/EP4349337A4/en active Pending
- 2022-05-23 CN CN202280036238.2A patent/CN117440810A/zh active Pending
-
2023
- 2023-11-22 US US18/517,448 patent/US20240099975A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9220786B2 (en) | Pharmaceutical composition of chelating complex micelles | |
| ES2616047T3 (es) | Liposomas útiles para la administración de fármacos | |
| US10596116B2 (en) | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders | |
| Tachikawa et al. | Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy | |
| ES2704986T3 (es) | Combinaciones de una camptotecina liposomal soluble en agua con cetuximab o bevacizumab | |
| EP2783679B1 (en) | Drug carrier with chelating composite micelle and use thereof | |
| JP2012158602A5 (https=) | ||
| Kang et al. | Advances in drug delivery system for platinum agents based combination therapy | |
| SI2477699T1 (en) | Medical use of spla2 hydrolysable liposomes | |
| JPWO2022250013A5 (https=) | ||
| JP2021504446A5 (https=) | ||
| KR20030081496A (ko) | 테가푸르, 우라실, 폴린산, 파클리탁셀 및 카르보플라틴투여를 통한 종양 치료 방법 및 이들의 투여 형태 | |
| CN101060886A (zh) | 用于组合治疗的包封放射性核素和细胞毒性剂的脂质体 | |
| US9579404B2 (en) | Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof | |
| JP2013504590A5 (https=) | ||
| RU2012114146A (ru) | Нерадиоактивные фосфолипидные соединения, композиции и способы их применения | |
| CN107714650A (zh) | 一种含谷氨酰胺代谢抑制剂脂质体及其药物组合物与用途 | |
| JPWO2022250015A5 (https=) | ||
| Mei | Review of the toxicological mechanism of anticancer drug cisplatin | |
| JP7755318B2 (ja) | リポソーム組成物及びその調製方法 | |
| JP2013227347A5 (https=) | ||
| JP5780637B2 (ja) | ホウ素１０同位体を含むホウ素化合物を内封したリポソーム | |
| JP2021518443A5 (https=) | ||
| CN106913522A (zh) | 硫酸长春新碱脂质体及制备方法和应用 | |
| US20140135390A1 (en) | Modified Platinum Compounds |